Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,767
Closed -$555K 906
2024
Q1
$555K Buy
+50,767
New +$303K 0.01% 784
2022
Q4
Sell
-70,669
Closed -$1.19M 945
2022
Q3
$1.19M Hold
70,669
0.01% 701
2022
Q2
$678K Sell
70,669
-59,600
-46% -$999K 0.01% 805
2022
Q1
$3.41M Sell
130,269
-5,000
-4% -$140K 0.03% 632
2021
Q4
$5.69M Sell
135,269
-75,127
-36% -$3.36M 0.04% 534
2021
Q3
$6.15M Sell
210,396
-3,400
-2% -$98.9K 0.05% 541
2021
Q2
$5.7M Buy
+213,796
New +$5.35M 0.04% 581

Other funds holding NOTV

Royce & Associates's NOTV Position: Q2 2024 in Review

Royce & Associates sold out of Inotiv (NOTV) in Q2 2024, closing a stake of 50,767 shares — an estimated $555K sold.

Royce & Associates first reported a position in NOTV in Q2 2021 and held it in 7 quarters. The position peaked at $6.15M in Q3 2021. 57 funds tracked by Wall St. Rank hold NOTV as of Q2 2024.

  • Royce & Associates reported no remaining Inotiv position as of Q2 2024 after selling out during the quarter.
  • Royce & Associates sold 50,767 Inotiv shares in Q2 2024, an estimated $555K.
  • Royce & Associates first reported a position in Inotiv in Q2 2021 and held it in 7 quarters.
  • Royce & Associates's Inotiv position peaked at $6.15M in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Inotiv as of Q2 2024.

Based on Royce & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.